Gritstone Announces Presentations during Three Upcoming Investor Conferences
♫ Saturday, January 1st, 2022EMERYVILLE, Calif., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, today announced that Gritstone management will participate in the following upcoming investor conferences in January.
Read this article:
Gritstone Announces Presentations during Three Upcoming Investor Conferences